000 | 01105 a2200277 4500 | ||
---|---|---|---|
005 | 20250516013630.0 | ||
264 | 0 | _c20110512 | |
008 | 201105s 0 0 eng d | ||
022 | _a1366-5928 | ||
024 | 7 |
_a10.3109/00498254.2010.535219 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMarvalin, Cyrille | |
245 | 0 | 0 |
_aMicrobial production of phase I and phase II metabolites of propranolol. _h[electronic resource] |
260 |
_bXenobiotica; the fate of foreign compounds in biological systems _cMar 2011 |
||
300 |
_a175-86 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAbsidia _xmetabolism |
650 | 0 | 4 |
_aAdrenergic beta-Antagonists _xchemistry |
650 | 0 | 4 | _aBiotransformation |
650 | 0 | 4 |
_aCunninghamella _xmetabolism |
650 | 0 | 4 |
_aPropranolol _xchemistry |
650 | 0 | 4 | _aStereoisomerism |
700 | 1 | _aAzerad, Robert | |
773 | 0 |
_tXenobiotica; the fate of foreign compounds in biological systems _gvol. 41 _gno. 3 _gp. 175-86 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.3109/00498254.2010.535219 _zAvailable from publisher's website |
999 |
_c20403506 _d20403506 |